Dr. Ivan Luptak Jr., MD

Dr. Luptak practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Luptak's NPI, 1962650853, was assigned on September 4, 2008. Dr. Luptak holds Massachusetts license 237871.

Dr. Luptak's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Luptak's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. Dr. Luptak is also affiliated with Sturdy Memorial Hospital. The medical group on file is Steward Medical Group. Dmand AI also links Dr. Luptak to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Luptak practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Luptak's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Luptak is licensed in Massachusetts.

CMS data shows 228 Medicare services from Dr. Luptak across 4 procedure codes in 2024, for 169 Medicare patients. Medicare paid $18,414 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 169 Medicare patients who saw Dr. Luptak in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Luptak's median patient age at 62, with 47% women.

In 2024, Dr. Luptak wrote 500 Medicare Part D claims for 61 patients. 67% of them were for generic drugs. CMS names the drug for 439 of them, across 12 drugs with 11 or more claims each, at $128,303 in total drug cost. In 2023, CMS named 425 claims across 13 drugs.

Dr. Luptak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Luptak from 2 drug and device companies from 2016 to 2018. Consulting fees make up the largest share, 66% of the total. Amgen Inc. paid the most, $3,020.